Sign in
4/A

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-25-000123

Options or other derivatives

  • Chief Executive Officer acquired 10,320 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2024-12-23 Grant or award · Stock Option (Right to Buy) +10,320 $4.80 $49,536 132,688 D
Loading xslF345X05/ownership.xml…